Lam Research
LRCX
$320.59
-2.71%
Lam Research Corp is one of the world's largest semiconductor wafer fabrication equipment manufacturers, specializing in deposition and etch processes that build up and selectively remove material layers during chip production. The company holds the top market share in etch and the clear second position in deposition, giving it a critical chokepoint role in the semiconductor supply chain, with a customer base that includes TSMC, Samsung, Intel, and Micron and a notable skew toward memory chipmakers for DRAM and NAND. The current investor narrative centers on Lam's position as a primary beneficiary of the AI infrastructure build-out, with recent headlines debating whether the company could become the next $1 trillion enterprise and highlighting billionaire investors adding chip-equipment names to their AI trades. This enthusiasm is tempered by recurring 'sell the news' episodes in semiconductor stocks and by the stock's sharp drawdowns, which reflect the market's debate over whether AI-driven equipment demand is durable or cyclical.…
LRCX
Lam Research
$320.59
Related headlines
Investment Opinion: Should I buy LRCX Today?
The synthesized recommendation is Hold, with a bias toward accumulating on pullbacks. The core thesis is that Lam Research is a high-quality, AI-driven growth story with strong fundamentals, but the current valuation already reflects much of the near-term optimism, as the average analyst target of $375.06 implies only 7.9% upside. The analyst consensus is strong buy (mean 1.46), but the risk/reward is balanced given the high beta and cyclical exposure.
Supporting evidence includes: revenue growth of 29.99% YoY in Q4 2026, gross margin expansion to 51.75%, net margin of 33.9%, and trailing free cash flow of $4.89 billion. The forward PE of 29.6x is reasonable if earnings materialize, but the trailing PE of 70.97x is near historical highs. The PEG ratio of 1.83 suggests the valuation is not egregiously stretched relative to growth, but the PS ratio of 22.2x is elevated. Analyst estimates for EPS of $17.30 and revenue of $55.75 billion imply continued growth, but the stock's 136.4% one-year gain already captures much of this.
The biggest risks are a cyclical slowdown in memory capex, valuation compression, and high volatility (beta 1.859). The rating would upgrade to Buy if the stock pulls back to the $290-$300 range (analyst low target) or if forward earnings estimates are raised. It would downgrade to Sell if revenue growth decelerates below 15% or if gross margins fall below 48%. Relative to its history and peers, the stock is fairly valued to slightly overvalued, trading at a premium justified by superior margins and ROE but vulnerable to any disappointment.
Sign up to view all
LRCX 12-Month Price Forecast
Lam Research presents a balanced risk/reward at current levels. The company's strong fundamentals, including accelerating revenue growth and expanding margins, are offset by a valuation that already prices in significant optimism. The forward PE of 29.6x is reasonable if earnings materialize, but the trailing PE of 70.97x leaves little room for error. Analyst sentiment is bullish, but the modest upside to the average target suggests limited near-term gains. I would upgrade to bullish if the stock pulls back to the $290-$300 range or if forward earnings estimates are raised, and downgrade to bearish if revenue growth decelerates below 15% or if gross margins fall below 48%.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Lam Research's 12-month outlook, with a consensus price target around $375.65 and implied upside of +17.2% versus the current price.
Average Target
$375.65
0 analysts
Implied Upside
+17.2%
vs. current price
Analyst Count
—
covering this stock
Price Range
$290 - $500
Analyst target range
Lam Research is covered by 31 analysts, and the consensus is strongly bullish with a recommendation of 'strong_buy' and a recommendation mean of 1.46 (where 1.0 is a strong buy). The average price target is $375.06, which implies approximately 7.9% upside from the current price of $347.49, while the consensus estimated EPS average of $17.30 and estimated revenue average of $55.75 billion point to continued growth expectations. The bullish consensus is reinforced by recent institutional ratings, which show a steady stream of Buy and Outperform reiterations from firms including UBS, Mizuho, Wells Fargo, Morgan Stanley, Jefferies, and Needham through mid-2026, with no downgrades visible in the provided data. The target price range spans from a low of $290.00 to a high of $500.00, a spread of $210 or roughly 72% of the low target, indicating meaningful dispersion in analyst views. The high target of $500 implies about 44% upside and likely assumes multiple expansion on accelerating AI-driven demand, successful penetration of advanced nodes, and continued margin expansion toward the high end of historical ranges. The low target of $290, roughly 16.5% below the current price, likely prices in a cyclical slowdown in memory and logic capex, margin compression, or a broader semiconductor correction. The wide spread signals high uncertainty typical of a high-beta, cyclical equipment name, and while the consensus leans bullish, the modest 7.9% upside to the average target suggests much of the near-term optimism is already reflected in the price, making execution against the forward earnings ramp the critical catalyst.
Bulls vs Bears: LRCX Investment Factors
The bull case currently has stronger evidence, driven by accelerating revenue growth (30% YoY), expanding margins (gross margin up to 51.75%), and a strong analyst consensus (strong buy, 1.46 mean). However, the bear case is compelling due to the elevated trailing PE of 70.97x, high beta of 1.859, and modest 7.9% upside to the average target. The single most important tension is whether the forward earnings ramp (estimated EPS of $17.30 vs. trailing $0.014) will materialize; if it does, the forward PE of 29.6x is defensible, but any disappointment could trigger a severe multiple compression given the stock's history of sharp drawdowns.
Bullish
- Revenue accelerating at 30% YoY: Fiscal Q4 2026 revenue reached $6.72 billion, up 29.99% year-over-year, marking the fourth consecutive quarter of sequential growth from $4.37 billion in the December 2024 quarter. This acceleration is driven by AI-related capacity investment from both memory and logic customers, shifting the narrative from cyclical recovery to structural growth.
- Margin expansion demonstrates operating leverage: Gross margin expanded to 51.75% in Q4 2026 from 49.6% in the December 2025 quarter, while operating margin rose to 37.4% from 33.9% over the same period. Net margin reached 33.9% in the latest quarter, well above the trailing 31.3%, reflecting pricing power in etch and deposition and scale benefits.
- Strong balance sheet and cash generation: Debt-to-equity is a conservative 0.33, current ratio is 2.63, and trailing free cash flow is $4.89 billion. With $5.60 billion in cash and exceptional returns on equity (58.3%) and assets (22.8%), the company funds growth, dividends, and buybacks internally.
- Analyst consensus strong buy with 7.9% upside: 31 analysts rate the stock a strong buy (mean 1.46), with an average target price of $375.06 implying 7.9% upside from $347.49. The high target of $500 suggests 44% upside, reflecting confidence in AI-driven demand and margin expansion.
Bearish
- Trailing PE of 70.97x near multi-year high: The trailing PE of 70.97x is near the top of its historical band (ranging from 8.9x in September 2022 to 56.4x in June 2026), signaling that the market is pricing in optimistic earnings growth. Any disappointment in the AI capex cycle could compress both earnings and the multiple simultaneously.
- High beta and severe drawdown risk: Beta of 1.859 means the stock is roughly 86% more volatile than the market, and its maximum drawdown of -41.76% underscores the severity of corrections. The stock fell from $433.33 on June 30 to $252.35 on July 29, a 41.8% drop in one month, highlighting cyclical risk.
- Modest upside to average analyst target: The average target price of $375.06 implies only 7.9% upside from the current price of $347.49, suggesting much of the near-term optimism is already reflected. The wide target range ($290 to $500) indicates high uncertainty and dispersion in analyst views.
- Memory-heavy customer mix adds volatility: Lam is more exposed to memory chipmakers for DRAM and NAND, which introduces periodic order volatility. The semiconductor equipment industry is cyclical, and a slowdown in memory capex could disproportionately impact Lam's revenue and margins.
LRCX Technical Analysis
Lam Research is in a powerful primary uptrend, with the stock up 136.4% over the past year and 87.8% year-to-date, massively outperforming the S&P 500's 15.0% and 12.9% respective gains. At a current price of $347.49, the stock sits at roughly 69.7% of its 52-week range (low of $131.02, high of $438.50), meaning it has recovered strongly from its lows but remains about 20.8% below its 52-week high, positioning it in a constructive mid-to-upper range rather than at euphoric highs. This positioning suggests the stock retains upside room toward prior highs while no longer offering the deep-value entry that existed near the 52-week low. Recent momentum has re-accelerated sharply: the stock is up 20.5% over the past month versus a 0.6% gain for SPY, a relative strength of 19.9 percentage points, and it has gained 59.1% over six months. However, the 3-month change of -1.1% (with relative strength of -4.5% versus SPY) reveals a mid-summer consolidation and pullback phase, including a decline from the June 30 high of $433.33 to a July 29 low of $252.35, before the current rebound. This divergence between strong 1-month and 1-year performance against a slightly negative 3-month reading signals that the stock has completed a corrective phase and is now reasserting its longer-term uptrend, with the October 2 close of $347.49 marking a fresh short-term high on the recovery leg. Key technical levels are well defined: immediate resistance sits at the 52-week high of $438.50, and a decisive breakout above that level would confirm trend continuation and likely invite momentum-driven flows, while support rests near the 52-week low of $131.02, with intermediate support around the July low of $252.35. The stock's beta of 1.859 means it is roughly 86% more volatile than the broader market, a critical consideration for position sizing, and its maximum drawdown of -41.76% underscores the severity of corrections this name can experience, making risk management and stop discipline essential even within a bullish trend.
Beta
1.85
1.85x market volatility
Max Drawdown
-41.8%
Largest decline past year
52-Week Range
$131-$439
Price range past year
Annual Return
+124.9%
Cumulative gain past year
| Period | LRCX Return | S&P 500 |
|---|---|---|
| 1m | +0.1% | +1.0% |
| 3m | -8.5% | +2.5% |
| 6m | +21.6% | +13.9% |
| 1y | +124.9% | +15.0% |
| ytd | +73.2% | +13.5% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
LRCX Fundamental Analysis
Lam Research's revenue trajectory is clearly accelerating: fiscal Q4 2026 (ended June 28, 2026) revenue reached $6.72 billion, up 29.99% year-over-year, building on a sequential climb from $5.34 billion in Q2 2026 and $5.84 billion in Q3 2026. The multi-quarter trend is unambiguously upward, with revenue rising from $4.37 billion in the December 2024 quarter to the latest $6.72 billion, and the system segment contributing $4.25 billion alongside $2.47 billion from customer support and other, indicating broad-based demand across both new tool sales and the recurring service business. This acceleration, driven by AI-related capacity investment from memory and logic customers, implies that the investment case has shifted from cyclical recovery to structural growth, though the memory-heavy customer mix introduces periodic order volatility. Profitability is robust and expanding: Q4 2026 net income was $2.28 billion on a 33.9% net margin, with gross margin at 51.75% and operating margin at 37.4%, up from a 49.6% gross margin and 33.9% operating margin in the December 2025 quarter. The company's trailing net margin of 31.3% and gross margin of 50.5% are strong for the semiconductor equipment industry, reflecting pricing power in etch and deposition, and the steady margin expansion over recent quarters demonstrates operating leverage as volumes scale. The balance sheet and cash generation are healthy: debt-to-equity is a conservative 0.33, the current ratio is 2.63, and trailing free cash flow is $4.89 billion, though quarterly FCF has been uneven, ranging from $0.81 billion in Q4 2026 to $1.67 billion in Q2 2026, partly due to working capital swings and heavy buybacks. Return on equity of 58.3% and return on assets of 22.8% are exceptional, and with $5.60 billion in cash at the end of Q4 2026 against modest debt, the company funds its growth, dividends, and repurchases internally; the dividend yield of just 0.25% with a payout ratio of 17.5% confirms capital return is weighted heavily toward buybacks rather than income.
Quarterly Revenue
$6.7B
2026-06
Revenue YoY Growth
+30.0%
YoY Comparison
Gross Margin
51.7%
Latest Quarter
Free Cash Flow
$4.9B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is LRCX Overvalued?
Because Lam Research is solidly profitable, with trailing net income of $2.28 billion in the latest quarter and positive EPS, the PE ratio is the appropriate primary valuation metric. The stock trades at a trailing PE of 70.97x versus a forward PE of 29.60x, a dramatic gap that implies the market expects earnings to more than double over the next year, consistent with consensus estimated EPS of $17.30 versus the trailing figure. This steep trailing-to-forward compression reflects both the cyclical trough-to-peak earnings ramp underway and the market's confidence in AI-driven equipment demand. Relative to the broader semiconductor sector, Lam's forward PE of 29.6x and PS ratio of 22.2x represent a premium, though the company's 31.3% net margin and 58.3% ROE are well above typical industry levels, providing fundamental justification for the premium; the PEG ratio of 1.83 suggests the valuation is not egregiously stretched relative to expected growth. On other metrics, the price-to-book ratio of 41.35x and EV/EBITDA of 59.08x are elevated, reflecting the asset-light model and the market's willingness to pay up for quality and growth in the AI supply chain. Historically, Lam's PE has ranged widely: it stood at 56.4x in the June 2026 quarter, 34.2x in March 2026, and as low as 8.9x in September 2022 during the last downcycle, while its PS ratio has ranged from roughly 10x in late 2022 to 76.7x in mid-2026. The current trailing PE of 70.97x is near the top of its multi-year band, signaling that the market is pricing in optimistic earnings growth, while the forward PE of 29.6x is more moderate and suggests that if earnings materialize as expected, the valuation is defensible; the key risk is that any disappointment in the AI capex cycle would compress both earnings and the multiple simultaneously.
PE
71.0x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 9x~35x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
59.1x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks are moderate but notable. The company carries a conservative debt-to-equity of 0.33 and a current ratio of 2.63, but its quarterly free cash flow has been uneven, ranging from $0.81 billion in Q4 2026 to $1.67 billion in Q2 2026, partly due to working capital swings and heavy buybacks. Revenue is concentrated in the semiconductor equipment market, with a notable skew toward memory chipmakers for DRAM and NAND, exposing it to periodic order volatility. Additionally, the trailing PE of 70.97x relies on a forward earnings ramp that must materialize to justify the valuation; any earnings miss could lead to a sharp correction.
Market and competitive risks are significant. The stock trades at a premium to the broader semiconductor sector, with a forward PE of 29.6x and PS ratio of 22.2x, leaving it vulnerable to valuation compression if growth slows. Its beta of 1.859 means it is roughly 86% more volatile than the market, amplifying sector rotation risk. Recent news highlights 'sell the news' episodes in semiconductor stocks, such as the July 7, 2026, Nasdaq drop triggered by Samsung's strong earnings, signaling potential overvaluation in AI-related sectors. Regulatory headwinds, such as export controls to China, could also impact demand.
In a worst-case scenario, a cyclical downturn in memory and logic capex, combined with margin compression and a broader semiconductor correction, could drive the stock toward its 52-week low of $131.02 or the analyst low target of $290. From the current price of $347.49, a decline to $290 represents a 16.5% loss, while a drop to the 52-week low would be a 62.3% loss. Given the maximum drawdown of -41.76%, investors could realistically lose 40-60% in an adverse scenario, underscoring the need for strict risk management.
FAQ
The key risks include: 1) Cyclical risk: A slowdown in memory and logic capex could reduce demand for Lam's equipment, as the company is more exposed to memory chipmakers for DRAM and NAND. 2) Valuation risk: The trailing PE of 70.97x is near historical highs, and any earnings miss could trigger a sharp correction. 3) Macro and market risk: With a beta of 1.859, the stock is highly sensitive to market downturns, and its maximum drawdown of -41.76% shows the potential severity. 4) Competitive and regulatory risk: Export controls to China and competition from Applied Materials and Tokyo Electron could impact market share and revenue. These risks are ranked from highest to lowest severity, with cyclical and valuation risks being the most immediate.
The 12-month forecast includes three scenarios: Bull case (30% probability) with a target range of $438-$500, assuming robust AI demand and margin expansion; Base case (50% probability) with a target range of $350-$400, assuming steady execution and moderate growth; Bear case (20% probability) with a target range of $250-$290, assuming a cyclical downturn. The base case is most likely, with the key assumption that revenue growth moderates to 15-20% YoY and forward EPS meets the consensus of $17.30. The average analyst target of $375.06 aligns with the base case, implying 7.9% upside from the current price.
LRCX appears fairly valued to slightly overvalued on a trailing basis, with a PE of 70.97x near its multi-year high, but the forward PE of 29.6x is more reasonable if earnings grow as expected. The PS ratio of 22.2x and EV/EBITDA of 59.08x are elevated compared to peers, but justified by the company's 31.3% net margin and 58.3% ROE. The PEG ratio of 1.83 suggests the valuation is not egregiously stretched relative to growth. The market is pricing in a significant earnings ramp, with estimated EPS of $17.30 versus trailing EPS of $0.014, implying that any disappointment could lead to multiple compression. Relative to its own history, the stock is at the higher end of its valuation range.
LRCX is a good buy for long-term investors seeking exposure to the AI semiconductor supply chain, but the current risk/reward is balanced. The stock trades at $347.49, with an average analyst target of $375.06 implying 7.9% upside, and a high target of $500 suggesting 44% upside. However, the trailing PE of 70.97x is elevated, and the stock's beta of 1.859 means it can be volatile. The biggest downside risk is a cyclical slowdown in memory capex, which could push the stock toward the analyst low target of $290 (16.5% downside) or the 52-week low of $131.02 (62.3% downside). For investors with a high risk tolerance and a 3-5 year horizon, accumulating on pullbacks below $300 could be prudent.
LRCX is more suitable for long-term investment (3-5 years) given its strong fundamentals, critical role in the AI supply chain, and consistent margin expansion. The company has a low dividend yield of 0.25% and a payout ratio of 17.5%, so it is not an income stock. Its high beta of 1.859 and maximum drawdown of -41.76% make it unsuitable for short-term trading unless using strict risk management. Earnings visibility is moderate, with quarterly volatility due to cyclical demand. A suggested minimum holding period is 3 years to ride out semiconductor cycles and benefit from the AI infrastructure build-out.

